Sputnik V trials to start next week

Clinical trials on the Sputnik V vaccine against the coronavirus disease 2019 (Covid-19) involving 40,000 volunteers start next week in Russia as development health authorities in the Philippines, which hopes to be one of the first beneficiaries of the serum, will be closely monitoring.

Kirill Dmitriev, chief executive officer of the Russia Direct Investment Fund, said the trials would be a “randomized, double-blind, placebo-controlled” type.